logo
episode-header-image
Oct 30
35m 6s

Hot Topics: Current Barriers to Myeloid ...

Neuro-Oncology
About this episode

Dr. Daniel Zamler interviews Dr. Amy Heimberger on the current limitations to myeloid therapy- specific discussions include combination therapies, plasticity of myeloid cells, translation, patient stratification and outlook.

Podcast Host and Interviewee: 

Host: Dr. Daniel Zamler

Interviewee: Dr. Amy Heimberger

Up next
Today
SNO 2026 Meeting: Education Day Co-Chair Interview
In this podcast episode, host Dr. Shreya Louis interviews two of the four education day co-chairs, Dr. Praveen Raju and Dr. Jian Campian, on what to expect from education day at the annual SNO meeting taking place in Philadelphia. Podcast Host and Interviewee: Host: Dr. Shreya Lo ... Show More
8m 58s
Nov 6
SNObound: Career advice with neuroradiologist Dr. Marco Pinho
Dr. Ruham Nasany and Jayden interview Dr. Marco Pinho, neuroradiologist at UT Southwestern Medical Center. The interview centers around Dr. Pinho's path prior to his current role, his day-to-day routine, and his views on the future of neuroradiology. Podcast Host and Interviewee: ... Show More
26m 45s
Nov 2
Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy—A retrospective analysis
Dr. Jasmin Jo interviews Dr. Haroon Ahmad and Dr. Lily Pham on their recent manuscript, titled "Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chime ... Show More
19m 28s
Recommended Episodes
Nov 2025
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More
9m 36s
Apr 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Dec 2022
Metagenomics of Parkinson Disease Implicates the Gut Microbiome in Multiple Disease Mechanisms
<p>Dr. Jason Crowell talks with Prof. Haydeh Payami, Professor of Neurology and Genetics at the University of Alabama at Birmingham, about how the gut microbiome may play a role in Parkinson disease according to metagenomics.</p> <p><span data-sheets-value= "{"1":2,"2":"Dr. Gregg ... Show More
16m 39s
Jul 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More
17m 45s
Apr 2024
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
tail spinning
19m 57s
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
Jul 2023
New Treatment for IDH mt Gliomas
<p><span class= "WdYUQQ text-decoration-none text-strikethrough-none">Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.</span></p> <p><span class= "WdY ... Show More
18m 19s
Apr 2024
Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer
Interview with Evan M. Graboyes, MD, MPH, author of Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer 
19m 56s
Feb 2024
Lung Cancer Screening with Low Dose CT
Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke an ... Show More
36m 43s
Oct 2025
Spotlight on Acute Myeloid Leukemia
In this Spotlight series episode on Acute Myeloid Leukemia, Blood Editor, Dr. Selina Luger interviews Drs. Laura Michaelis and Alexander Perl on their paper in the series titled “The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based fron ... Show More
21m 39s
Listen to millions of songs and podcasts on Anghami